167 filings
15F-12B
CXRXF
ADVANZ PHARMA Corp.
26 Nov 19
Securities registration termination (foreign)
2:05pm
15-12B
CXRXF
ADVANZ PHARMA Corp.
28 Jan 19
Securities registration termination
3:10pm
6-K
CXRXF
ADVANZ PHARMA Corp.
6 Dec 18
Current report (foreign)
2:56pm
6-K
CXRXF
ADVANZ PHARMA Corp.
29 Nov 18
Current report (foreign)
5:12pm
6-K
CXRXF
ADVANZ PHARMA Corp.
29 Nov 18
Special Meeting of Holders of Limited Voting Shares
12:31pm
S-8 POS
baf87xnrisi 7tl5eb2
29 Nov 18
Registration of securities for employees (post-effective amendment)
12:01pm
6-K
s4e 76ztmmmy7
14 Nov 18
Concordia International Corp. Announces Third Quarter 2018 Results
3:52pm
6-K
zan77c98jd3 bbixulqs
8 Nov 18
Current report (foreign)
12:00am
6-K
jtzha96
1 Nov 18
Concordia International Corp. Announces Release Date for Third Quarter 2018 Results
12:00am
6-K
zqjns69fdnft918g
29 Oct 18
Concordia International Corp. Adds European Pharmaceutical Industry Expert to its Board of Directors
10:27am
6-K
ntcxu
16 Oct 18
Concordia International Corp. Announces Addition of Pharmaceutical Industry Expert to its Board of Directors
12:00am
6-K
mh7x4hmly5el
9 Oct 18
Concordia International Corp. Announces Intention To Rebrand As ADVANZ PHARMA Following Its Successful Recapitalization
10:43am
6-K
mlec47e qk
5 Oct 18
Current report (foreign)
5:04pm
D
qrzdl4wz6
18 Sep 18
$586.5M in equity, sold $228.03M, 8 investors
12:00am
6-K
qo9 lbs00rfo84esc
14 Sep 18
Current report (foreign)
12:00am
6-K
vyn3dsra
14 Sep 18
Current report (foreign)
12:00am
6-K
903bo5m
12 Sep 18
Current report (foreign)
12:00am
6-K
cfwy0m mg1
11 Sep 18
Concordia International Corp. Provides Update On Its Recently Completed Recapitalization Transaction
12:00am
6-K
1il0 g04d
7 Sep 18
Concordia International Corp. Completes Recapitalization Transaction
12:00am
6-K
awey0zp1f8
23 Aug 18
Credit and Guaranty Agreement
12:00am